Driving CAR T-cell Therapy in New Directions
Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and...
Tag: immunotherapy
Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and...
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
At AACR IO 2026, Nobel laureate Fred Ramsdell explained the research history of regulatory T cells (Tregs) and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
Elizabeth M. Jaffee and Antoni Ribas will look to feature the next wave of immuno-oncology advances as Cancer Immunology Research's...
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...